Combination Iron Chelation Therapy
NCT00004982
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
NIH
Sponsor class
Conditions
Iron Overload
Thalassemia
Interventions
DRUG:
Combination Iron Chelation Therapy
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)